Ken Gall

Professor Gall is currently the Associate Dean of Entrepreneurship and Professor of Mechanical Engineering and Materials Science at Duke University. His expertise is in the mechanical behavior of materials with emphasis on the creation, modification, understanding, and commercialization of synthetic biomaterials. His publications have been cited nearly 20,000 times with an H-index of 76. He is a founder and director of five active medical device start-ups (Restor3d, Lacuna, Pressio, Huxley, and Penderia). He is also a Director in four other early stage medical device companies (DeepBlue, InnAVasc, Kinos, and Orthobond).

He was a founder and board member of two medical device startups, MedShape and Vertera, that have been acquired by public strategics for a total of $215M on a total of $18.7 in annual sales. MedShape was acquired through two different exits, their sports medicine division was acquired by Conmed and their foot and ankle division was acquired by Colfax-DJO. Vertera was acquired by Nuvasive.